Drug Database · Clinicians

Guaifenesin + Phenylpropanolamine hc1 chlorphenamine

Also known as: chlorpheniramine (US name, for chlorphenamine) · guaiphenesin (former British name, for guaifenesin)

Brands (1) PluragenShow all

This entry appears to be Chlorphenamine + Guaifenesin + Phenylpropanolamine registered under a variant spelling.

See the main Chlorphenamine + Guaifenesin + Phenylpropanolamine monograph (kidney dosing, prescribing information, all brands) →

Antihistamine/Nasal Decongestant/Expectorant PH FDA category
Fixed-dose combination.

Controlled precursorOTC · Over-the-counter1 PH product

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 100 mg 6.5 mg/2 mg per 45 mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Guaifenesin + Phenylpropanolamine hc1 chlorphenamine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Guaifenesin + Phenylpropanolamine hc1 chlorphenamine
Package insert
PluragenGuaifenesin + Phenylpropanolamine HC1 Chlorphenamine Maleate
100 mg 6.5 mg/2 mg per 45 mL Syrup (Cherry Flavor)Boston Round Amber Bottle x 60 mL & 120 mL (Box of 1's)
OTC
Azarias Pharmaceutical LaboratoriesPhilippines
Trader: Eba Generisch Trading Inc.
DRP-16407
Mar 4, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .